How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study

BACKGROUND: Neuromuscular blocking agents (NMBAs) have been shown to improve the outcome of the most severely hypoxemic, acute respiratory distress syndrome (ARDS) patients. However, the recommended dosage as well as the necessity of monitoring the neuromuscular block is unknown. We aimed to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hraiech, Sami, Forel, Jean-Marie, Guervilly, Christophe, Rambaud, Romain, Lehingue, Samuel, Adda, Mélanie, Sylla, Pierre, Valera, Sabine, Carvelli, Julien, Gainnier, Marc, Papazian, Laurent, Bourenne, Jérémy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540745/
https://www.ncbi.nlm.nih.gov/pubmed/28770545
http://dx.doi.org/10.1186/s13613-017-0305-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540745/
https://www.ncbi.nlm.nih.gov/pubmed/28770545
http://dx.doi.org/10.1186/s13613-017-0305-2

Ejemplares similares